News • COVID-19
Chewing gum could reduce SARS-CoV-2 transmission
In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus.
Coronavirus
News • COVID surveillance
Mobile robot detects social distancing breaches
A new strategy to reduce the spread of COVID-19 employs a mobile robot that detects people in crowds who are not observing social-distancing rules, navigates to them, and encourages them to move apart.
News • Patient immunity
COVID-19 variants: Rapid test identifies antibody effectiveness
Test could measure patient immunity against multiple COVID-19 variants such as Omicron and Delta at once and inform which synthetic monoclonal antibody to use for treatments.
Sponsored • Coronavirus antigen detection
An innovative test for the early diagnosis of Covid-19
Compared to previous SARS and MERS, SARS-CoV-2 became a pandemic due to the high infectivity and different mode of contagion. SARS-CoV-2 spreads more because it is contagious also before symptoms, during incubation phase. No tests to date have been able to find the virus during the pre-symptomatic stage. Stark has developed a new, rapid, non-invasive method "Stark Portable Covid-19 Antigen…
Article • Accelerating the pace of development
Fighting the pandemic with microfluidic
The Corona pandemic has a major impact on all areas of life. Nearly everyone is affected in some way – in their health, in their jobs, in their entire lives. But there are also notable bright spots. Chief among these effects is the rapid development of vaccines, test kits and, in the future, medicines that are making a significant contribution to overcoming the crisis. Microfluidic components…
News • Coronavirus imaging
Brightest ever X-ray shows lung damage from Covid-19
The damage caused by Covid-19 to the lungs’ smallest blood vessels has been intricately captured using high-energy X-rays emitted by a special type of particle accelerator. Scientists used a new imaging technology called Hierarchical Phase-Contrast Tomography (HiP-CT), to scan donated human organs, including lungs from a Covid-19 donor.
News • Gender equality in clinical trials
Women in Covid-19 research: a good start, but...
There has been a "positive shift" in inclusive gender practices in Covid-19 vaccine research, but there is still room for improvement, experts say. Women have been equally recruited and represented in randomised control trial research about Covid-19 vaccine safety, efficacy and effectiveness, according to a new study by The George Institute for Global Health and The Australian National…
News • Team sports research
Coronavirus and soccer: study investigates transmission risk
A study by the Universities of Basel and Saarland shows that there is almost no risk of transmission of the Covid-19 virus on the field. They suggest that blanket quarantine measures for opposing teams are not justified if no close contact has taken place off the playing field. Governments have introduced various measures over the past 18 months in an effort to curb transmission of the Covid-19…
News • Addressing coronavirus vaccine hesitancy
Covid-19: Could a chatbot help overcome vaccine concerns?
French researchers have found that addressing concerns related to the Covid-19 vaccination via a chatbot interface might be capable of swaying the vaccine-hesitant. Vaccine hesitancy is one of the major challenges in containing the Covid-19 pandemic. Previous studies have revealed that mass communication—through short messages relayed by television or radio—is not a very effective means of…
News • Covid-19 & influenza
Will there be a twindemic?
“Twindemic” is a term that has not yet been in the headlines but is likely to become part of our lexicon as the summer progresses.
News • Coronavirus inhibition
Highly potent antibody against SARS-CoV-2 discovered
Scientists at Lausanne University Hospital (CHUV) and École polytechnique fédérale de Lausanne (EPFL) have discovered a highly potent monoclonal antibody that targets the SARS-CoV-2 spike protein and is effective at neutralizing all variants of concern identified to date, including the delta variant. Their findings are published in the journal Cell Reports.
News • Rapid detection
Molecular diagnostic test for Covid-19, Flu, RSV receives CE mark
A new rapid molecular diagnostic test from Cepheid has received the CE mark for distribution in the European market. The test, called Xpert Xpress CoV-2/Flu/RSV plus, is designed for qualitative detection of the viruses causing Covid-19, Flu A, Flu B, and respiratory syncytial virus (RSV) infections from a single patient sample. The new plus version of the test provides a third gene target for…
News • Genomic tracking
Retracing the Covid-19 pandemic in England
The Covid-19 crisis that gripped England between September 2020 and June 2021 can be thought of as a series of overlapping epidemics, rather than a single event, say researchers at the Wellcome Sanger Institute, EMBL's European Bioinformatics Institute (EMBL-EBI) and the German Cancer Research Center.
News • Fighting antibacterial resistance
Continued COVID levels of hygiene could transform infection control
Making recommendations for change, academics analyzed global data into the prevalence of antimicrobial resistance in urban areas—the rise of which is threatening the lifesaving role of the medications.
News • Immune response study
Is a "natural" Covid-19 infection better than vaccination? It's complicated
Hope for a future without fear of Covid-19 comes down to circulating antibodies and memory B cells. Unlike circulating antibodies, which peak soon after vaccination or infection only to fade a few months later, memory B cells can stick around to prevent severe disease for decades. And they evolve over time, learning to produce successively more potent “memory antibodies” that are better at…
News • Immunological memory
How our lungs 'remember' a Covid-19 infection
After infection with SARS-CoV-2, where does the immune system store the memory to provide long-term protection against reinfection? Though numerous studies have examined blood to track immune responses to SARS-CoV-2, a new study of Covid survivors shows that the memory of the infection is primarily stored in T and B cells within the lung and the lymph nodes surrounding the lung.
News • Nosocomial infection prevention
Improving hospital hand hygiene compliance with smart measurement system
Water, hygiene and infection prevention solutions and services provider Ecolab launches its Hand Hygiene Compliance Measurement (HHCM) System, a digitally connected technology to systematically monitor and improve hand hygiene in healthcare settings, across Europe. In healthcare settings, clean hands save lives. While the Covid-19 outbreak increased adoption of hand hygiene measures at first,…
Article • Covid-19 and pathology
Lung cancer care across Europe affected by coronavirus pandemic
The impact of the coronavirus pandemic on lung cancer patient care across Europe, and the contribution lung pathologists, have led to a better understanding of Covid-19, as outlined during the 33rd European Congress of Pathology, Within ‘The lung pathologist in the Covid-19 pandemic’ session, speakers detailed how the pandemic has affected patients, diagnosis and clinical trials, yet also…
News • Colorectal cancer study
Covid-19 pandemic slashes CRC diagnoses by over 40%
The number of colorectal cancer (CRC) cases diagnosed fell dramatically by 40% in a year during the Covid-19 pandemic, new research presented at United European Gastroenterology (UEG) Week Virtual 2021 has shown. The research, which was conducted across multiple hospitals in Spain, compared data from the first year of the Covid-19 pandemic with data from the previous year. Of 1,385 cases of CRC…
News • Covid-19 and beyond
Safe transport system for infectious patients gets innovation award
Medical technology startup EpiGuard has received the 2021 Oslo Innovation Award. Presented during the first day of the of Oslo Innovation Week, the Scandinavian city’s annual technology festival, Ellen Cathrine Andersen, CEO of EpiGuard, collected the award from Vegar Andersen, advisor for the City of Oslo’s Vice Mayor for Business Development and Public Ownership.
News • Research
Covid-19 infection increases risk for preeclampsia
A study found that women who contract Covid-19 during pregnancy are at significantly higher risk of developing pre-eclampsia. In their study, researchers said their systematic review shows that women with SARS-CoV-2 infection during pregnancy had 62% higher odds of developing preeclampsia than those without the infection during pregnancy.
News • In children
Long COVID symptoms rarely persist beyond 12 weeks
Long COVID symptoms rarely persisted beyond 12 weeks in children and adolescents unlike adults.
News • High risk patients
WHO recommends antibody treatment for Covid-19 patients
A treatment combining two antibodies is recommended for two specific groups of patients with Covid-19 by a WHO Guideline Development Group panel of international experts and patients.
News • Better ventilation needed
COVID-19 virus gets better at becoming airborne
Study suggests need for better ventilation and tight-fitting masks, in addition to widespread vaccination to help stop spread of the virus.
News • QCovid tool
Vaccinated groups at highest risk of Covid-19 hospitalisation
According to new research, vaccinated people are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.
